If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,780.50
Bid: 1,778.50
Ask: 1,779.00
Change: 7.00 (0.39%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,786.50
Low: 1,771.50
Prev. Close: 1,773.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Upbeat corporate guidances lift European shares, Nvidia forecast boosts chip stocks

Thu, 23rd Feb 2023 17:22

UK healthcare giants fall on ex-dividend trades

*

WPP leads gains among media stocks

*

AXA rises on guidance hike, surprise share buy-back

*

Rolls-Royce jumps on upbeat profit outlook for 2023

*

Euro zone inflation marginally higher in Jan; core also lifted

*

STOXX 600 up 0.1%

Feb 23 (Reuters) - European shares inched higher on Thursday, after two straight sessions of declines, supported by financial stocks and upbeat guidance by regional companies, while U.S. semiconductor designer Nvidia's positive sales forecast sparked a rally in chip stocks.

The pan-European STOXX 600 index rose 0.1%.

AXA

rose 3.2% after the French insurer raised its 2023 guidance and announced a share buy-back programme, while posting lower-than-expected full-year earnings.

Banks gained 0.9%, while insurers added 0.3%.

Also aiding sentiment, data earlier in the day showed that euro zone inflation was only a

touch higher

than earlier estimated in January, confirming that price growth is now well past its peak.

The rate-sensitive technology sector rose 0.4%, supported by a jump in semiconductor stocks.

Chipmakers ASM International, BE Semiconductor and Aixtron gained between 0.4% and 1.2%.

U.S. peer Nvidia Corp forecast first-quarter revenue above Wall Street estimates on Wednesday, noting a strong boost from the use of its chips in artificial intelligence (AI) services such as chatbots.

The shorter-term demand for chips will get a boost to fuel "an AI gold rush, if you think such a phenomenon will actually materialize," said Greg Bassuk, chief executive at AXS Investments.

However, the worries of central banks raising interest rates for longer still lingered.

The minutes from the U.S. Federal Reserve's last policy meeting released on Wednesday showed nearly all policymakers rallied behind a decision to further slow the pace of interest rate hikes, noting inflation would determine how much further rates needed to rise.

"The starkest takeaway was, arguably, that some policymakers could have gotten behind another 50 basis point increase and all backed further tightening ahead," said Craig Erlam, senior market analyst at OANDA.

Recent data showed French and German economic activity moved into growth territory, while a rebound in U.S. business activity also backed views that interest rates in both economies will remain higher for longer.

Still, the STOXX 600 has risen nearly 9% so far this year, more than double the S&P 500 index's 3.9% rise.

Europe has benefited from better weather, hopes that the economy will narrowly avoid a recession and a boost from China's reopening.

Engineering firm Rolls-Royce surged 23.7%, to the top of the STOXX 600, after the company's CEO forecast more profit growth in 2023 after last year's profit beat expectations.

Auto stocks rose 1.0%, with carmaker Stellantis up 3.6%.

Media stocks were up 0.3%, boosted by a 3.4% rise in British ad group WPP after it forecast better-than-expected organic growth of 3% to 5% for the year.

UK banks and healthcare majors fell, weighing on the FTSE 100 index. Barclays, Standard Chartered , AstraZeneca and GSK fell as they traded without an entitlement for dividend payout. (Reporting by Shreyashi Sanyal in Bengaluru; Editing by Subhranshu Sahu, Savio D'Souza and Andrew Heavens)

More News
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.